Gastroenterology — MCQs

Gastroenterology Indian Medical PG Practice Questions and MCQs

Question 841: Which of the following viruses does not produce viral esophagitis?

A. Herpes simplex virus
B. Adenovirus (Correct Answer)
C. Varicella zoster virus
D. Cytomegalovirus

Explanation: **Explanation:** Viral esophagitis is a common cause of odynophagia and dysphagia, particularly in immunocompromised patients (e.g., HIV/AIDS, transplant recipients, or those on chemotherapy). **Why Adenovirus is the correct answer:** While **Adenovirus** is a common cause of respiratory infections, conjunctivitis, and gastroenteritis (diarrhea), it is **not** a recognized cause of infectious esophagitis. The esophagus is rarely, if ever, a target organ for Adenovirus, even in severely immunocompromised states. **Analysis of incorrect options:** * **Herpes simplex virus (HSV):** HSV-1 is the most common viral cause of esophagitis in healthy individuals and the second most common in AIDS patients. It typically presents with small, "punched-out" ulcers (volcano-like) and characteristic Cowdry Type A inclusion bodies on biopsy. * **Cytomegalovirus (CMV):** CMV is the most common viral cause of esophagitis in AIDS patients. Unlike HSV, it produces large, shallow, linear ulcerations. Biopsy shows "owl’s eye" intranuclear inclusions. * **Varicella zoster virus (VZV):** Though rare, VZV can cause esophagitis, usually in children with chickenpox or adults with disseminated shingles. It presents with vesicles and ulcers similar to HSV. **High-Yield Clinical Pearls for NEET-PG:** * **HSV Esophagitis:** Biopsy should be taken from the **edge** of the ulcer (where the virus replicates in squamous cells). * **CMV Esophagitis:** Biopsy should be taken from the **base** of the ulcer (as it affects subepithelial endothelial cells and fibroblasts). * **Treatment:** Acyclovir is the drug of choice for HSV/VZV; Ganciclovir is the drug of choice for CMV. * **Candida albicans** remains the overall most common cause of infectious esophagitis.

Question 842: Which of the following has the least predilection for the distal ileum?

A. Carcinoid syndrome
B. Meckel's diverticulum
C. Crohn disease
D. Zollinger-Ellison syndrome (Correct Answer)

Explanation: **Explanation:** The correct answer is **Zollinger-Ellison syndrome (ZES)**. This question tests your knowledge of the anatomical distribution of gastrointestinal pathologies. **Why ZES is the correct answer:** Zollinger-Ellison syndrome is characterized by gastrin-secreting tumors (gastrinomas). These tumors are primarily located in the **"Gastrinoma Triangle"** (confluence of the cystic and common bile ducts, the junction of the second and third portions of the duodenum, and the neck/body of the pancreas). While ZES causes severe peptic ulcers, these occur most commonly in the **duodenum** (75%) and stomach, not the distal ileum. **Analysis of Incorrect Options:** * **Carcinoid syndrome:** The most common site for gastrointestinal carcinoid tumors is the **distal ileum**, followed by the appendix and rectum. * **Meckel's diverticulum:** This is a vestigial remnant of the vitellointestinal duct located typically **2 feet proximal to the ileocaecal valve** (distal ileum). It often contains ectopic gastric mucosa. * **Crohn’s disease:** While it can affect any part of the GIT, the **terminal (distal) ileum** is the most common site of involvement (ileocolic distribution) [1]. **High-Yield Clinical Pearls for NEET-PG:** * **Gastrinoma Triangle Boundaries:** Junction of cystic/CBD, 2nd/3rd part of duodenum, and neck of pancreas. * **Rule of 2s for Meckel’s:** 2 inches long, 2 feet from ileocaecal valve, 2% of population, presents by age 2, contains 2 types of ectopic tissue (gastric/pancreatic). * **Crohn’s vs. UC:** Crohn’s is transmural and favors the terminal ileum; Ulcerative Colitis is mucosal and always involves the rectum, never the small bowel (except "backwash ileitis") [1].

Question 843: A young man is brought to casualty with a history of hematemesis and mild splenomegaly on examination. What is the most likely cause of bleeding?

A. Gastritis
B. Esophageal varices (Correct Answer)
C. Tumor
D. Leukemia

Explanation: **Explanation:** The presence of **hematemesis** (vomiting of blood) [1] combined with **splenomegaly** (enlarged spleen) [4] in a young patient is a classic clinical triad pointing towards **Portal Hypertension** [2]. In this context, the most likely cause of significant upper gastrointestinal bleeding is **Esophageal Varices** [3]. 1. **Why Esophageal Varices is correct:** Portal hypertension leads to the formation of collateral circulation at the gastroesophageal junction [3]. These dilated veins (varices) are prone to rupture, causing massive hematemesis. In young patients, this is often due to **Extrahepatic Portal Venous Obstruction (EHPVO)** or Non-Cirrhotic Portal Fibrosis (NCPF), where splenomegaly is a prominent finding due to congestive hypersplenism [3]. 2. **Why other options are incorrect:** * **Gastritis:** While a common cause of hematemesis, it does not explain the presence of splenomegaly [1]. * **Tumor:** Gastric or esophageal tumors can cause bleeding, but they are rare in young men and do not typically present with isolated splenomegaly unless there is advanced metastatic liver disease. * **Leukemia:** While leukemia can cause splenomegaly and bleeding (due to thrombocytopenia), the bleeding is usually systemic (petechiae, mucosal bleeds) [4] rather than isolated massive hematemesis. **NEET-PG High-Yield Pearls:** * **Most common cause of massive hematemesis in children/young adults in India:** EHPVO. * **Most common cause of portal hypertension worldwide:** Cirrhosis of the liver [2]. * **Clinical Sign:** "Cruveilhier-Baumgarten murmur" may be heard over the epigastrium in portal hypertension. * **Management:** The immediate drug of choice for suspected variceal bleed is **Octreotide** or **Terlipressin**, followed by definitive Endoscopic Variceal Ligation (EVL).

Question 844: Pruritus precedes jaundice in which of the following conditions?

A. Primary biliary cirrhosis (Correct Answer)
B. Secondary biliary cirrhosis
C. Primary sclerosing cholangitis
D. Common bile duct stone

Explanation: **Explanation:** The hallmark clinical feature of **Primary Biliary Cholangitis (PBC)**—formerly known as Primary Biliary Cirrhosis—is that **pruritus precedes jaundice**, often by months or even years [1]. **1. Why Primary Biliary Cholangitis is correct:** PBC is a chronic, autoimmune cholestatic liver disease characterized by the destruction of small intrahepatic bile ducts. The early accumulation of bile acids and other pruritogens in the systemic circulation triggers intense itching long before the bilirubin levels rise high enough to cause visible jaundice [1]. In fact, pruritus is the most common presenting symptom in approximately 50% of patients. **2. Analysis of Incorrect Options:** * **Secondary Biliary Cirrhosis:** This results from prolonged large-duct obstruction (e.g., strictures). Here, jaundice and pruritus typically develop concurrently as the obstruction affects the entire biliary tree simultaneously. * **Primary Sclerosing Cholangitis (PSC):** While PSC also presents with cholestasis, it typically involves both intra- and extra-hepatic ducts. Patients often present with fatigue or jaundice first, or are diagnosed incidentally via abnormal LFTs in the setting of Ulcerative Colitis. * **Common Bile Duct (CBD) Stone:** This causes acute extrahepatic obstruction. Jaundice usually appears rapidly and is often accompanied by biliary colic (pain). Pruritus, if present, occurs alongside the jaundice. **High-Yield Clinical Pearls for NEET-PG:** * **Serology:** 95% of PBC patients are **Anti-Mitochondrial Antibody (AMA) positive** (M2 subtype). * **Demographics:** Classically affects middle-aged women (Female:Male ratio is 9:1). * **Associated Findings:** Look for xanthelasma, hypercholesterolemia, and associations with other autoimmune diseases (Sjögren’s, Hashimoto’s) [1]. * **Treatment:** **Ursodeoxycholic acid (UDCA)** is the first-line treatment to slow progression.

Question 845: Palmar erythema is seen in which of the following conditions?

A. Congestive Cardiac Failure (CCF)
B. Acute Renal Failure (ARF)
C. Chronic Renal Failure (CRF)
D. Hepatic failure (Correct Answer)

Explanation: **Explanation:** **Palmar erythema** is a clinical sign characterized by a symmetrical, mottled reddening of the palms, primarily involving the thenar and hypothenar eminences. **1. Why Hepatic Failure is Correct:** In chronic liver disease and hepatic failure, the liver’s ability to metabolize and clear circulating hormones is impaired [1]. The primary mechanism is **hyperestrogenism** (increased serum estradiol levels). Estrogen has a potent vasodilatory effect on the terminal capillaries and small blood vessels of the hand. Additionally, increased levels of nitric oxide and other vasoactive substances contribute to peripheral vasodilation, leading to the characteristic "liver palms." **2. Why Other Options are Incorrect:** * **Congestive Cardiac Failure (CCF):** CCF typically presents with peripheral cyanosis or cold extremities due to low cardiac output and compensatory vasoconstriction, rather than vasodilation [2]. * **Acute Renal Failure (ARF):** ARF is characterized by rapid electrolyte imbalances and fluid overload; it does not typically present with chronic cutaneous stigmata like palmar erythema. * **Chronic Renal Failure (CRF):** While CRF can cause skin changes (e.g., pruritus, uremic frost, or hyperpigmentation), palmar erythema is not a classic feature [3]. **3. NEET-PG High-Yield Pearls:** * **Other causes of Palmar Erythema:** Pregnancy (due to high estrogen), Thyrotoxicosis, Rheumatoid Arthritis, and Chronic Alcoholism. * **Liver Stigmata:** Palmar erythema often co-exists with **Spider Naevi** (Spider Angiomas). Both are attributed to hyperestrogenism. * **Distribution:** It typically spares the central part of the palm and is non-tender and blanchable. * **Clinical Significance:** While common in cirrhosis, it is not specific to the liver; however, in the context of a NEET-PG question, it is the classic "textbook" sign of chronic liver disease [4].

Question 846: Which of the following anatomical locations is MOST commonly affected in Ulcerative Colitis (UC)?

A. Cecum
B. Rectum (Correct Answer)
C. Sigmoid colon
D. Terminal ileum

Explanation: **Explanation:** **Ulcerative Colitis (UC)** is a chronic inflammatory bowel disease characterized by diffuse, continuous mucosal inflammation. The hallmark of UC is that it **always involves the rectum** (proctitis) and extends proximally in a continuous fashion without "skip lesions" [1]. Therefore, the rectum is the most commonly affected site and is involved in nearly 100% of cases at the time of diagnosis. **Analysis of Options:** * **A. Cecum:** While UC can involve the cecum (pancolitis), it is rarely the primary or most common site. A "cecal patch" (periappendiceal inflammation) can sometimes be seen in distal UC, but the rectum remains the primary site. * **C. Sigmoid colon:** The sigmoid is frequently involved as the disease spreads proximally from the rectum (proctosigmoiditis), but it is not the starting point or the most common site compared to the rectum. * **D. Terminal ileum:** This is the classic site for **Crohn’s Disease**. In UC, the ileum is generally spared, except in cases of "backwash ileitis," where the terminal ileum shows superficial inflammation in the setting of severe pancolitis. **High-Yield NEET-PG Pearls:** * **Distribution:** Continuous and symmetrical; starts in the rectum and moves proximally [1]. * **Depth of Involvement:** Limited to the **mucosa and submucosa** (unlike Crohn’s, which is transmural) [1]. * **Microscopic Feature:** **Crypt abscesses** and crypt distortions are characteristic [1]. * **Smoking Paradox:** Smoking is protective in UC (it may worsen Crohn’s). * **Surgery:** Proctocolectomy is curative for UC.

Question 847: Autoimmune hepatitis is associated with which of the following antibodies?

A. Anti-LKM antibody
B. ANA (Correct Answer)
C. ANA (anti-neutrophil cytoplasmic antibody)
D. SLA-antibody

Explanation: Autoimmune Hepatitis (AIH) is a chronic inflammatory liver disease characterised by the presence of serum antibodies and peripheral blood T lymphocytes reactive with self-proteins [1]. It is classified into two main types based on the antibody profile: * **Type 1 AIH:** This is the most common form worldwide. It is characterized by the presence of **Antinuclear Antibodies (ANA)** and/or **Anti-Smooth Muscle Antibodies (ASMA)** [1]. ANA is the most frequently detected antibody, being present in nearly 100% of cases, making it the hallmark of the classic form of the disease [2]. * **Type 2 AIH:** This type is more common in children and is characterized by **Anti-Liver Kidney Microsome-1 (Anti-LKM1)** antibodies and Anti-Liver Cytosol-1 (Anti-LC1) antibodies. **Analysis of Options:** * **Option B (ANA):** Correct. ANA is the most common and characteristic marker for Type 1 AIH, which accounts for 80% of all AIH cases [2]. * **Option A (Anti-LKM):** While associated with Type 2 AIH, it is less common overall than ANA. * **Option C (ANCA):** Perinuclear ANCA (p-ANCA) can be found in 50% of patients with AIH, but it is more classically associated with Primary Sclerosing Cholangitis (60-80%) [1]. * **Option D (SLA):** Anti-Soluble Liver Antigen (SLA) is highly specific for AIH but is only present in about 20-30% of patients. **High-Yield Clinical Pearls for NEET-PG:** * **Gold Standard Diagnosis:** Liver biopsy showing **Interface Hepatitis** (piecemeal necrosis) and plasma cell infiltration [1]. * **Treatment:** Corticosteroids (Prednisolone) alone or in combination with Azathioprine [1]. * **Demographics:** Predominantly affects young to middle-aged females. * **Association:** Often associated with other autoimmune conditions like Type 1 Diabetes, Thyroiditis, and Celiac disease [1].

Question 848: What is the first line of treatment in ascites?

A. Salt Restriction (Correct Answer)
B. Diuretics
C. Paracentesis
D. Shunt

Explanation: The management of ascites, particularly in the context of cirrhosis, follows a stepwise approach. The fundamental pathophysiology involves portal hypertension leading to splanchnic vasodilation and subsequent activation of the renin-angiotensin-aldosterone system (RAAS), which causes significant **sodium and water retention**. **1. Why Salt Restriction is Correct:** The **first-line treatment** for any patient with Grade 2 (moderate) ascites is a **sodium-restricted diet** [1]. The goal is to achieve a negative sodium balance. Guidelines (AASLD/EASL) recommend limiting sodium intake to **2 grams (88 mmol) per day** [1]. In approximately 10-15% of patients (especially those with first-onset ascites), salt restriction alone may be sufficient to initiate diuresis and reduce fluid accumulation [1]. **2. Analysis of Incorrect Options:** * **B. Diuretics:** These are considered the second step or are added simultaneously if salt restriction alone is insufficient [1]. The standard regimen is a combination of Spironolactone (aldosterone antagonist) and Furosemide (loop diuretic). * **C. Paracentesis:** Large-volume paracentesis (LVP) is the treatment of choice for **Grade 3 (tense) ascites** or refractory ascites, but it is not the initial "first-line" step for routine management. * **D. Shunt:** Portosystemic shunts (like TIPS) are reserved for **refractory ascites** that does not respond to medical therapy (salt restriction + diuretics). **Clinical Pearls for NEET-PG:** * **Fluid Restriction:** This is **not** required unless serum sodium drops below **120–125 mmol/L**. * **Weight Loss Goal:** In patients with edema, the goal is 1 kg/day; without edema, it is 0.5 kg/day. * **Spironolactone to Furosemide Ratio:** To maintain normokalemia, the ideal ratio is **100:40 mg**. * **SAAG Score:** A Serum-Ascites Albumin Gradient **≥ 1.1 g/dL** indicates portal hypertension.

Question 849: Which of the following is NOT an indicator for endoscopy in a patient with GERD symptoms?

A. Anemia
B. Weight loss
C. Epigastric burning pain (Correct Answer)
D. Choking episodes

Explanation: In the management of Gastroesophageal Reflux Disease (GERD), endoscopy is not routinely required for diagnosis. The diagnosis is primarily clinical, based on classic symptoms like heartburn and regurgitation. **Explanation of the Correct Answer:** **Option C (Epigastric burning pain)** is a typical symptom of uncomplicated GERD or dyspepsia. In the absence of "alarm features," these patients are initially managed with lifestyle modifications and a trial of Proton Pump Inhibitors (PPIs). Endoscopy is reserved for patients who fail empirical therapy or those presenting with "red flags." **Analysis of Incorrect Options (Alarm Symptoms):** The other options represent **Alarm Symptoms** that necessitate immediate endoscopic evaluation to rule out malignancy, strictures, or severe ulceration [1]: * **Anemia (Option A):** Suggests chronic occult gastrointestinal bleeding, potentially from erosive esophagitis, Barrett’s esophagus, or esophageal adenocarcinoma. * **Weight Loss (Option B):** An unintentional loss of weight is a classic systemic sign of malignancy or significant nutritional impairment due to dysphagia [1]. * **Choking Episodes (Option D):** Indicates potential aspiration or a structural abnormality (like a structural stricture or ring) causing dysphagia or bolus impaction [1]. **NEET-PG High-Yield Pearls:** * **Indications for Endoscopy in GERD:** Age >50–55 years (new onset), dysphagia, odynophagia, persistent vomiting, GI bleeding, anemia, weight loss, or symptoms refractory to PPI therapy [1]. * **Gold Standard for Diagnosis:** While endoscopy detects complications, **24-hour pH monitoring** is the most sensitive test for diagnosing GERD itself. * **Barrett’s Esophagus:** Endoscopy with biopsy is mandatory for screening in patients with chronic GERD (>5 years) and multiple risk factors (male, white, obese, smoker) [2].

Question 850: A 20-year-old male presented with jaundice for the past 2 weeks. His liver function tests revealed serum bilirubin to be 0.9 mg/dL, SGOT/SGPT to be 1240/1450 IU. He was found to be positive for HBsAg and IgM anti-HEV antibodies and negative for IgM anti-HBc. What is the most likely diagnosis?

A. Acute hepatitis with mutant hepatitis B virus
B. Superinfection of hepatitis E virus with chronic hepatitis B infection (Correct Answer)
C. Acute hepatitis with wild type hepatitis B virus
D. Co-infection of hepatitis B and E viruses

Explanation: ### Explanation The diagnosis hinges on interpreting the serological markers and the severity of transaminase elevation. **1. Why Option B is Correct:** * **Chronic HBV Status:** The patient is **HBsAg positive** but **IgM anti-HBc negative**. IgM anti-HBc is the hallmark of acute Hepatitis B infection. Its absence indicates that the patient is a chronic carrier of HBV rather than suffering from a new acute HBV infection [1]. The persistence of HBsAg for longer than 6 months indicates chronic infection [1]. * **Acute HEV Infection:** The presence of **IgM anti-HEV** confirms a recent/acute infection with Hepatitis E [2]. * **Superinfection Concept:** When an acute viral hepatitis (HEV in this case) occurs in a known chronic carrier of another hepatitis virus (HBV), it is termed a **superinfection**. The massive elevation of SGOT/SGPT (1240/1450 IU) reflects the acute hepatic injury caused by the HEV superinfection [2]. **2. Why Incorrect Options are Wrong:** * **Option C & D:** Both suggest **Acute HBV**. If the HBV infection were acute (either alone or as a co-infection), the patient **must** be positive for **IgM anti-HBc** [1]. Since he is negative, acute HBV is ruled out. * **Option A:** A "mutant" HBV (like a Pre-core mutant) usually refers to HBeAg-negative chronic hepatitis. It does not explain the acute IgM anti-HEV positivity or the lack of IgM anti-HBc in an acute presentation. **3. NEET-PG Clinical Pearls:** * **Window Period:** The period where HBsAg becomes negative but Anti-HBs hasn't appeared yet. **IgM anti-HBc** is the only marker positive during this time [1]. * **HEV in Pregnancy:** Hepatitis E has a high mortality rate (up to 20%) in pregnant women due to fulminant hepatic failure. * **Transaminase Levels:** Levels >1000 IU/L are typically seen in acute viral hepatitis, toxin/drug-induced injury (e.g., Paracetamol), or ischemic hepatitis ("shock liver").

Practice by Chapter

Esophageal Disorders

Practice Questions

Peptic Ulcer Disease

Practice Questions

Inflammatory Bowel Disease

Practice Questions

Irritable Bowel Syndrome

Practice Questions

Malabsorption Syndromes

Practice Questions

Pancreatitis (Acute and Chronic)

Practice Questions

Gastrointestinal Bleeding

Practice Questions

Liver Diseases and Cirrhosis

Practice Questions

Viral Hepatitis

Practice Questions

Biliary Tract Disorders

Practice Questions

Gastrointestinal Motility Disorders

Practice Questions

Gastrointestinal Malignancies

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free